Indaptus Therapeutics Inc (INDP) Stock Analysis

Indaptus Therapeutics Inc (INDP) is a publicly traded company in the HEALTHCARE sector. It trades at $2.15, carries a market capitalization of $199.31M. This page summarizes the public market data, fundamentals, and frequently asked questions for INDP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.15
• Market Cap: $199.31M
• EPS: $-12.70
• 52-Week High: $19.91
• 52-Week Low: $0.92

Market Sentiment

Indaptus Therapeutics Inc currently has a Bearish sentiment score of -0.38.

About Indaptus Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Indaptus Therapeutics Inc (INDP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for INDP.

Frequently Asked Questions

Does INDP pay dividends?

Indaptus Therapeutics Inc (INDP) does not currently pay a regular dividend.

What is INDP's market cap?

Indaptus Therapeutics Inc (INDP) has a market capitalization of $199.31M with a current stock price of $2.15.